Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eric King
AddedFeb 15, 2024
UpdatedMay 31, 2026
Eric King

Eric King

Board Member, SaVia Health

CrunchbaseLinkedInThe Org

Eric King's Career

SaVia Health
SaVia Health

Salt Lake City, UT, US

Board Member· Board
Retrace
Retrace

San Francisco, CA, US

Board Member· Board
Medical Informatics
Medical Informatics

Houston, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eric King's Career

SaVia Health
SaVia Health

Salt Lake City, UT, US

Board Member· Board
Retrace
Retrace
Series A$18M1752016San Francisco, CA, US
Board Member· Board

Leadership at Retrace

Sherman LiSherman LiBoard Member
Ali SadatAli SadatCEO

Similar to Retrace

Modern TreasuryModern TreasuryCacheu Region, GWFinancial Operations, Paymentsest. 2018Modern TreasuryCacheu Region, GW · est. 2018

Modern Treasury automates payment cycles and enriches financial data via web or API.

Series C · $183.1M160
TrullionTrullionNew York City, NY, USAccounting Softwareest. 2019TrullionNew York City, NY, US · est. 2019

AI-powered platform for modern accounting leaders, automating workflows and lease accounting.

Series B · $33M75
CareStackCareStackOrlando, FL, USDental Softwareest. 2015CareStackOrlando, FL, US · est. 2015

CareStack: Comprehensive cloud-based dental software for scheduling, billing, and patient engagement.

Series D · $74.1M375
TrussTrussSan Francisco, CA, USBanking, Paymentsest. 2019TrussSan Francisco, CA, US · est. 2019

Truss: All-in-one banking & payment automation for construction firms.

Series A · $5.5M12
Medical Informatics
Medical Informatics
Series A$38.9M1752010Houston, TX, US
Board Member· Board

Leadership at Medical Informatics

Scott BarclayScott BarclayBoard Member
Emma FaussEmma FaussFounder
Mellie PriceMellie PriceBoard Member
Ali TamasebAli TamasebBoard Member

Similar to Medical Informatics

Mindset MedicalMindset MedicalScottsdale, AZ, USClinical Platform, Telehealthest. 2016Mindset MedicalScottsdale, AZ, US · est. 2016

Mindset Medical: Streamlining healthcare with a clinical platform for efficient patient-provider interaction.

Angel · $1.4M22
Real Time Medical SystemsReal Time Medical SystemsLinthicum Heights, MD, USHealthcare Analyticsest. 2011Real Time Medical SystemsLinthicum Heights, MD, US · est. 2011

Real Time Medical Systems: Enhancing patient care through healthcare interventional analytics.

Series C · $29.7M83
Ambient Clinical AnalyticsAmbient Clinical AnalyticsRochester, MN, USAnalytics Softwareest. 2013Ambient Clinical AnalyticsRochester, MN, US · est. 2013

Rochester-based software company, Ambient Clinical Analytics, provides clinical analytics solutions to health systems.

Angel · $11.8M33

People Similar to Eric King

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · Kakao